CFF Fluid Control Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:48 pm

Quick Insight

CFF Fluid Control Ltd, based in Maharashtra, currently trades at ₹630 with a market cap of ₹1,321 Cr. The company's P/E stands at 55.4, indicating a relatively high valuation, while its ROE and ROCE at 17.4% and 22.1% respectively suggest decent profitability and capital efficiency. With an OPM of 27% and a Net Profit of ₹24 Cr, CFF demonstrates operational strength. The firm's high Promoter holding of 73.30% provides stability, though the lack of FII and DII interest could be a concern. CFF's healthy ICR of 18.47x and P/BV ratio of 5.67x indicate strong financial health and investor confidence. Overall, CFF Fluid Control Ltd presents a mixed picture, with potential for growth but also some areas warranting further scrutiny.

Competitors of CFF Fluid Control Ltd

All Competitor Stocks of CFF Fluid Control Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:34 am

Below is a detailed analysis of the quarterly data for CFF Fluid Control Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 80.00 Cr. (Sep 2024) to 66.00 Cr., marking a decrease of 14.00 Cr..
• For Expenses, as of Mar 2025, the value is 48.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 57.00 Cr. (Sep 2024) to 48.00 Cr., marking a decrease of 9.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Sep 2024) to 18.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Mar 2025, the value is 27.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Sep 2024) to 27.00%, marking a decrease of 2.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to 14.00 Cr., marking a decrease of 5.00 Cr..
• For Tax %, as of Mar 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Sep 2024) to 29.00%, marking an increase of 3.00%.
• For Net Profit, as of Mar 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Sep 2024) to 10.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 5.03. The value appears to be declining and may need further review. It has decreased from 7.21 (Sep 2024) to 5.03, marking a decrease of 2.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:19 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:36 pm

Below is a detailed analysis of the balance sheet data for CFF Fluid Control Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 19.00 Cr..
• For Reserves, as of Mar 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 22.00 Cr..
• For Borrowings, as of Mar 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 23.00 Cr. (Mar 2024) to 21.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 18.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Mar 2024) to 199.00 Cr., marking an increase of 38.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 39.00 Cr..
• For Total Assets, as of Mar 2025, the value is 199.00 Cr.. The value appears strong and on an upward trend. It has increased from 161.00 Cr. (Mar 2024) to 199.00 Cr., marking an increase of 38.00 Cr..

Notably, the Reserves (128.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for CFF Fluid Control Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.25. This value is within the healthy range. It has increased from 9.21 (Mar 24) to 12.25, marking an increase of 3.04.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.25. This value is within the healthy range. It has increased from 9.21 (Mar 24) to 12.25, marking an increase of 3.04.
• For Cash EPS (Rs.), as of Mar 25, the value is 15.40. This value is within the healthy range. It has increased from 11.06 (Mar 24) to 15.40, marking an increase of 4.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.92. It has increased from 64.67 (Mar 24) to 75.92, marking an increase of 11.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.92. It has increased from 64.67 (Mar 24) to 75.92, marking an increase of 11.25.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 74.75. It has increased from 54.87 (Mar 24) to 74.75, marking an increase of 19.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 21.21. This value is within the healthy range. It has increased from 15.85 (Mar 24) to 21.21, marking an increase of 5.36.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 13.56 (Mar 24) to 18.06, marking an increase of 4.50.
• For PBT / Share (Rs.), as of Mar 25, the value is 16.91. This value is within the healthy range. It has increased from 12.32 (Mar 24) to 16.91, marking an increase of 4.59.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.25. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 12.25, marking an increase of 3.48.
• For PBDIT Margin (%), as of Mar 25, the value is 28.37. This value is within the healthy range. It has decreased from 28.88 (Mar 24) to 28.37, marking a decrease of 0.51.
• For PBIT Margin (%), as of Mar 25, the value is 24.16. This value exceeds the healthy maximum of 20. It has decreased from 24.72 (Mar 24) to 24.16, marking a decrease of 0.56.
• For PBT Margin (%), as of Mar 25, the value is 22.62. This value is within the healthy range. It has increased from 22.46 (Mar 24) to 22.62, marking an increase of 0.16.
• For Net Profit Margin (%), as of Mar 25, the value is 16.38. This value exceeds the healthy maximum of 10. It has increased from 15.99 (Mar 24) to 16.38, marking an increase of 0.39.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.13. This value is within the healthy range. It has increased from 13.56 (Mar 24) to 16.13, marking an increase of 2.57.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.96. This value is within the healthy range. It has increased from 19.93 (Mar 24) to 22.96, marking an increase of 3.03.
• For Return On Assets (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has increased from 10.60 (Mar 24) to 11.98, marking an increase of 1.38.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.14. This value is within the healthy range. It has decreased from 0.18 (Mar 24) to 0.14, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has decreased from 0.85 (Mar 24) to 0.80, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 3.49. This value exceeds the healthy maximum of 3. It has decreased from 4.24 (Mar 24) to 3.49, marking a decrease of 0.75.
• For Quick Ratio (X), as of Mar 25, the value is 2.19. This value exceeds the healthy maximum of 2. It has decreased from 2.40 (Mar 24) to 2.19, marking a decrease of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 4. It has decreased from 1.22 (Mar 24) to 0.79, marking a decrease of 0.43.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.16. This value is below the healthy minimum of 20. It has increased from 5.69 (Mar 24) to 8.16, marking an increase of 2.47.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 20. It has increased from 4.52 (Mar 24) to 6.49, marking an increase of 1.97.
• For Earning Retention Ratio (%), as of Mar 25, the value is 91.84. This value exceeds the healthy maximum of 70. It has decreased from 94.31 (Mar 24) to 91.84, marking a decrease of 2.47.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.51. This value exceeds the healthy maximum of 70. It has decreased from 95.48 (Mar 24) to 93.51, marking a decrease of 1.97.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 18.47. This value is within the healthy range. It has increased from 12.78 (Mar 24) to 18.47, marking an increase of 5.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.66. This value is within the healthy range. It has increased from 8.08 (Mar 24) to 11.66, marking an increase of 3.58.
• For Enterprise Value (Cr.), as of Mar 25, the value is 856.29. It has increased from 802.21 (Mar 24) to 856.29, marking an increase of 54.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.88. This value exceeds the healthy maximum of 3. It has decreased from 7.51 (Mar 24) to 5.88, marking a decrease of 1.63.
• For EV / EBITDA (X), as of Mar 25, the value is 20.73. This value exceeds the healthy maximum of 15. It has decreased from 25.99 (Mar 24) to 20.73, marking a decrease of 5.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.76. This value exceeds the healthy maximum of 3. It has decreased from 7.45 (Mar 24) to 5.76, marking a decrease of 1.69.
• For Retention Ratios (%), as of Mar 25, the value is 91.83. This value exceeds the healthy maximum of 70. It has decreased from 94.30 (Mar 24) to 91.83, marking a decrease of 2.47.
• For Price / BV (X), as of Mar 25, the value is 5.67. This value exceeds the healthy maximum of 3. It has decreased from 6.32 (Mar 24) to 5.67, marking a decrease of 0.65.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.76. This value exceeds the healthy maximum of 3. It has decreased from 7.45 (Mar 24) to 5.76, marking a decrease of 1.69.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness